Overview

Andrea Golan is a senior associate attorney in Vicente Sederberg’s Los Angeles office and a member of the firm’s Regulatory Compliance and Hemp and Cannabinoids Departments. Her practice focuses on advising businesses in ensuring compliance with regulatory requirements for cultivating, processing, testing, marketing, and selling cannabis products—including advising businesses with respect to the intersection of federal, state, and local laws.

Prior to joining VS, Andrea was an associate attorney at a national insurance defense firm, where her practice focused on commercial and business litigation, public entity defense, catastrophic injury, and medical malpractice.

Andrea graduated magna cum laude from Whittier Law School, where she served as research editor of the Whittier Law Review. Prior to law school, Andrea worked in customs and regulatory compliance, where she handled sourcing, manufacturing, laboratory testing, packaging, labeling, customs compliance, and factory audits and inspections for housewares and consumables. Andrea also worked as a congressional liaison officer for the Federal Emergency Management Agency, where she served as a liaison to Members of Congress and their congressional staffers to ensure they were informed of FEMA policies and programs, in addition to assisting individuals and communities with disaster recovery.

Experience

Leadership & Community Involvement

• Member, International Cannabis Bar Association
• Member, Cannabis Committee, American Herbal Products Association
• Member, Government Relations Committee, American Herbal Products Association

Publications

VS Insights

• Co-author, "5 Resolutions for Your California Cannabis Business," January 14, 2022

• Co-author, "Financing Adaptogenic Mushroom Companies: Seven Basic Regulatory Points to Understand," December 2, 2021

• Co-author, "California Department of Cannabis Control Files Emergency Rules," October 7, 2021

• Co-author, "California Now Permits the Manufacture and Retail Sale of Hemp-Derived Products — Including CBD," October 6, 2021

• Author, "California Trailer Bill Update: Impact on Cannabis Businesses," July 22, 2021

• Author, "Proposed Changes to Prop 65 ‘Short-Form’ Warning Option: What Cannabis and Hemp Operators Need to Know," March 17, 2021

• Co-author, "What Efforts Are Underway to Include Cannabis Businesses in COVID-19 Relief Packages?" January 28, 2021

• Co-author, "Where Did Cannabis Ballot Measures Win in California on Election Day 2020?" November 18, 2020

• Author, California Proposition 65 Warning Requirements Effective January 3, 2021," October 1, 2020

• Author, "Can Cannabis Businesses Defer Employment Taxes Due to the Coronavirus?" April 24, 2020

• Co-author, "A Closer Look at California COVID-19 Relief Programs," April 22, 2020

• Author, "The CARES Act: Impact on Hemp Businesses," April 17, 2020

• Author, "Prop 65 Warning Requirements for Cannabis, THC and CBD," April 13, 2020

Events

• Speaker, INCBA, "Hemp 201 - FDA and the Marketing of CBD products: Will FDA provide a regulatory pathway for CBD in 2021?,” Webinar, July 15, 2021
• Speaker, Vicente Sederberg LLP, "Webinar: Challenging a Cannabis License Denial,” Webinar, October 27, 2020
• Speaker, Alameda County Bar Association , "What Attorneys Should Know About the Legal Status of Hemp and CBD Products in California and Beyond,” Online, September 15, 2020
• Speaker, AHPA Hemp-CBD Supplement Virtual Congress, "Progress on FDA Interim Final Rule Implementation Workshop,” Online, August 20, 2020
• Speaker, Vicente Sederberg LLP, "California Cannabis Packaging and Labeling Compliance,” Webinar, July 15, 2020